GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
91.29
+1.01 (1.11%)
Aug 27, 2026, 9:56 AM EDT - Market open
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.72 billion as of August 27, 2026. Its market cap has decreased by -24.93% in one year.
Market Cap
2.72B
Enterprise Value
2.76B
1-Year Change
-24.93%
Ranking
Category
Stock Price
$91.29
ChartMarket Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.72B, a decrease of -84.79%. That is a compound annual growth rate of -27.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 2.72B | -27.58% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RadNet | 6.00B |
| Sotera Health Company | 5.57B |
| BillionToOne | 4.76B |
| Adaptive Biotechnologies | 4.19B |
| GRAIL | 3.60B |
| Veracyte | 3.51B |
| CareDx | 2.59B |
| NeoGenomics | 2.16B |